We are live on ! Find out more
RXST icon

RxSight
RXST

115 hedge funds and large institutions have $637M invested in RxSight in 2023 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 45 increasing their positions, 13 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,345% more call options, than puts

Call options by funds: $1.42M | Put options by funds: $98K

586% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 7

246% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 13

141% more capital invested

Capital invested by funds: $264M → $637M (+$373M)

55% more funds holding

Funds holding: 74 → 115 (+41)

18.17% more ownership

Funds ownership: 46.92% → 65.09% (+18%)

Holders
115
Holders Change
+41
Holders Change %
+55.41%
% of All Funds
1.81%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
48
Increased
45
Reduced
13
Closed
7
Calls
$1.42M
Puts
$98K
Net Calls
+$1.32M
Net Calls Change
+$283K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$32.3M
2
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$24.3M
3
Millennium Management
Millennium Management
New York
+$12.2M
4
ACM
Atika Capital Management
New York
+$11.4M
5
BlackRock
BlackRock
New York
+$8.5M

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$20.1M
2
Artisan Partners
Artisan Partners
Wisconsin
-$12.6M
3
BAM
Belpointe Asset Management
Nevada
-$1.76M
4
BM
Bridger Management
New York
-$1.65M
5
MF
Magnetar Financial
Illinois
-$1.47M
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
RA Capital Management
Massachusetts
$87.9M – – –
Artisan Partners
2
Artisan Partners
Wisconsin
$59.9M -$12.6M -568,171 -21%
BlackRock
3
BlackRock
New York
$46.9M +$8.5M +382,119 +31%
Morgan Stanley
4
Morgan Stanley
New York
$43.4M +$32.3M +1,451,598 +2,617%
Lord, Abbett & Co
5
Lord, Abbett & Co
New Jersey
$41.2M +$24.3M +1,092,431 +322%
Millennium Management
6
Millennium Management
New York
$35.5M +$12.2M +550,082 +81%
Vanguard Group
7
Vanguard Group
Pennsylvania
$33.9M +$3.54M +159,310 +16%
NCGI
8
Next Century Growth Investors
Minnesota
$24M -$960K -43,178 -5%
Point72 Asset Management
9
Point72 Asset Management
Connecticut
$16.5M +$4.99M +224,275 +64%
JP Morgan Chase
10
JP Morgan Chase
New York
$15.6M -$564K -25,372 -4%
ACM
11
Atika Capital Management
New York
$14.8M +$11.4M +514,000 New
PHP
12
Parkman Healthcare Partners
Connecticut
$14.4M +$1.58M +70,838 +17%
DCM
13
Driehaus Capital Management
Illinois
$13.6M +$60.2K +2,705 +0.6%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$13M +$1.18M +52,980 +13%
State Street
15
State Street
Massachusetts
$13M +$1.82M +81,959 +22%
Federated Hermes
16
Federated Hermes
Pennsylvania
$9.08M +$7.02M +315,414 New
Russell Investments Group
17
Russell Investments Group
United Kingdom
$8.24M +$4.71M +211,666 +285%
Two Sigma Investments
18
Two Sigma Investments
New York
$7.95M +$5.71M +256,673 +1,320%
Citadel Advisors
19
Citadel Advisors
Florida
$7.44M +$4.7M +211,154 +448%
Northern Trust
20
Northern Trust
Illinois
$6.41M +$845K +38,007 +21%
EI
21
EAM Investors
California
$6.38M +$1.1M +49,536 +29%
DSCM
22
Divisadero Street Capital Management
Florida
$5.76M +$4.45M +200,000 New
PAMP
23
Polar Asset Management Partners
Ontario, Canada
$5.55M +$2.61M +117,419 +156%
Norges Bank
24
Norges Bank
Norway
$5.34M +$4.13M +185,500 New
Voloridge Investment Management
25
Voloridge Investment Management
Florida
$5.25M +$4.05M +182,155 New
1
2 3 4 5

RXST Hedge Fund Activity: Q2 2023 in Review

115 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q2 2023, worth a combined $637M — up 141% from $264M a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new RXST positions and 7 closed out — a net gain of 41 holders — while 45 added to existing stakes and 13 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $32.3M. The largest seller was OrbiMed, exiting entirely with an estimated $20.1M sold.

  • 115 institutional investors held RxSight (RXST) as of Q2 2023, up from 74 in Q1 2023.
  • Funds reported $637M of RxSight stock for Q2 2023, up 141% quarter-over-quarter.
  • 48 funds opened new RxSight positions in Q2 2023 and 7 closed out, a net change of +41 holders.
  • The largest RxSight buyer in Q2 2023 was Morgan Stanley, an estimated $32.3M added.
  • The largest RxSight seller in Q2 2023 was OrbiMed, an estimated $20.1M sold.

Based on aggregated 13F filings for Q2 2023.